ARTIVION, INC. (AORT) Dividend Safety
- Dividend payout ratio · 12 months: Value (m); Formula and calculation Cash dividends paid / net income. Period ending 2026-06-30..
Dividend safety
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Dividend payout ratio · 12 months | (m) | Cash dividends paid / net income. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Dividend payments · 12 months | (m) | Payments of Dividends |
| Net income · 12 months | -3.17M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Dividend payments · 12 months (USD) | Net income · 12 months (USD) | Dividend payout |
|---|---|---|---|
| 2026-06-30 | (m) | $-3.17M | (m) |
| 2026-03-31 | (m) | $11.69M | (m) |
| 2025-12-31 | (m) | $9.77M | (m) |
| 2025-09-30 | (m) | $-9.14M | (m) |
| 2025-06-30 | (m) | $-17.93M | (m) |
| 2025-03-31 | (m) | $-21.40M | (m) |
| 2024-12-31 | (m) | $-13.36M | (m) |
| 2024-09-30 | (m) | $-851.00K | (m) |
| 2024-06-30 | (m) | $-8.36M | (m) |
| 2024-03-31 | (m) | $-9.63M | (m) |
| 2023-12-31 | (m) | $-30.69M | (m) |
| 2023-09-30 | (m) | $-24.55M | (m) |
| 2023-06-30 | (m) | $-28.46M | (m) |
| 2023-03-31 | (m) | $-29.34M | (m) |
| 2022-12-31 | (m) | $-19.19M | (m) |
| 2022-09-30 | (m) | $-41.46M | (m) |
| 2022-06-30 | (m) | $-17.17M | (m) |
| 2022-03-31 | (m) | $-15.09M | (m) |
| 2021-12-31 | (m) | $-14.83M | (m) |
| 2021-09-30 | (m) | $1.81M | (m) |
| 2021-06-30 | (m) | $-11.64M | (m) |
| 2021-03-31 | (m) | $-13.15M | (m) |
| 2020-12-31 | (m) | $-16.68M | (m) |
| 2020-09-30 | (m) | $-13.90M | (m) |
| 2020-06-30 | (m) | $-11.17M | (m) |
| 2020-03-31 | (m) | $-4.65M | (m) |
| 2019-12-31 | (m) | $1.72M | (m) |
| 2019-09-30 | (m) | $1.63M | (m) |
| 2019-06-30 | (m) | $3.32M | (m) |
| 2019-03-31 | (m) | $718.00K | (m) |
| 2018-12-31 | (m) | $-2.84M | (m) |
| 2018-09-30 | (m) | $-5.07M | (m) |
| 2018-06-30 | (m) | $-5.31M | (m) |
| 2018-03-31 | (m) | $-2.37M | (m) |
| 2017-12-31 | (m) | $3.70M | (m) |
| 2017-09-30 | (m) | $9.61M | (m) |
| 2017-06-30 | (m) | $11.28M | (m) |
| 2017-03-31 | (m) | $10.46M | (m) |
| 2016-12-31 | (m) | $10.78M | (m) |
| 2016-09-30 | (m) | $10.52M | (m) |
| 2016-06-30 | (m) | $9.67M | (m) |
| 2016-03-31 | (m) | $6.82M | (m) |
| 2015-12-31 | $3.41M | $4.00M | 85.09% |
| 2015-09-30 | $3.40M | $3.15M | 107.98% |
| 2015-06-30 | $3.38M | $3.33M | 101.77% |
| 2015-03-31 | $3.37M | $5.99M | 56.32% |
| 2014-12-31 | $3.29M | $7.32M | 45.00% |
| 2014-09-30 | $3.22M | $14.57M | 22.08% |
| 2014-06-30 | $3.13M | $15.41M | 20.33% |
| 2014-03-31 | $3.05M | $15.04M | 20.29% |
| 2013-12-31 | $2.97M | $16.17M | 18.35% |
| 2013-09-30 | $2.89M | $9.23M | 31.30% |
| 2013-06-30 | (m) | $7.60M | (m) |
| 2013-03-31 | (m) | $9.15M | (m) |
| 2012-12-31 | $1.37M | $7.95M | 17.28% |
| 2012-09-30 | (m) | $7.73M | (m) |
| 2012-06-30 | (m) | $8.21M | (m) |
| 2012-03-31 | (m) | $6.70M | (m) |
| 2011-12-31 | (m) | $7.37M | (m) |
| 2011-09-30 | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) |
| 2010-12-31 | (m) | $3.94M | (m) |
| 2010-09-30 | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) |
| 2009-12-31 | (m) | $8.68M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |